Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G58667NI
Summary
- GlyTouCan ID
-
G58667NI
- IUPAC Condensed
- Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc(b1-
- Motifs
- N-Glycan complex N-acetyllactosamine Type 2 LN
- Subsumption Level
- Fully-defined saccharide
- Monoisotopic Mass
- 1624.6
G74837KH
G67098LA
3D Structures
- GlycoNAVI
- G58667NI
- GlycoShape
- G58667NI
- GLYCAM
- DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-OH
Organisms
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Homo sapiens (human) | |
| Rattus norvegicus (Norway rat) |
Taxonomic Hierarchy
GlycoGene Database (GGDB)
KEGG BRITE Database
- KEGG ID
GALAXY
Glucose Units
- ODS
- 13.3
- Amide
- 6.4
- Degrading Enzymes
G29504BG
G66937TJ
G58635UO
G68937TM
G43694RQ
Glycans containing this structure in GALAXY
Core Protein
Sequence Descriptors
- GlycoCT
-
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl 3b:b-dglc-HEX-1:5 4s:n-acetyl 5b:b-dman-HEX-1:5 6b:a-dman-HEX-1:5 7b:b-dglc-HEX-1:5 8s:n-acetyl 9b:b-dgal-HEX-1:5 10b:a-dman-HEX-1:5 11b:b-dglc-HEX-1:5 12s:n-acetyl 13b:a-lgal-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:1o(4+1)3d 3:3d(2+1)4n 4:3o(4+1)5d 5:5o(3+1)6d 6:6o(2+1)7d 7:7d(2+1)8n 8:7o(4+1)9d 9:5o(6+1)10d 10:10o(2+1)11d 11:11d(2+1)12n 12:1o(6+1)13d
- WURCS
- WURCS=2.0/5,9,8/[a2122h-1b_1-5_2*NCC/3=O][a1122h-1b_1-5][a1122h-1a_1-5][a2112h-1b_1-5][a1221m-1a_1-5]/1-1-2-3-1-4-3-1-5/a4-b1_a6-i1_b4-c1_c3-d1_c6-g1_d2-e1_e4-f1_g2-h1
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 33242084 | Post-natal developmental changes in the composition of the rat neocortical N-glycome | Klarić Thomas S | 2021-06-03 |
|
| 34207636 | What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease? | Gaunitz S | 2021 Jun 9 |
|
| 33383989 | Bisecting GlcNAc Protein N-Glycosylation Is Characteristic of Human Adipogenesis | Wongtrakul-Kish K | 2021 Feb 5 |
|
| 31889402 | Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment | Schedin-Weiss Sophia | 2020-08 |
|
| 32841605 | Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor | Zhao P | 2020 Oct 07 |
|
| 30674035 | Exploring Cerebrospinal Fluid IgG N-Glycosylation as Potential Biomarker for Amyotrophic Lateral Sclerosis | Costa J | 2019 Jan 23 |
|
| 26455811 | CSF N-glycoproteomics for early diagnosis in Alzheimer's disease | Palmigiano Angelo | 2016-01-10 |
|
| 24680513 | Comparison of separation techniques for the elucidation of IgG N-glycans pooled from healthy mammalian species | Adamczyk B | 2014 May 07 |
|
| 20578731 | Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia | Stanta Johannes L | 2010-09-03 |
|
| 12652077 | Structural studies on IgG oligosaccharides of patients with primary Sjogren's syndrome | Kuroda Y | 2002 Jan |
|
